Loading...

Table of Content

    20 December 2024, Volume 19 Issue 12
    A Comprehensive Multi-omics and Multimodal Database of 10 k Chinese Stroke Patients (STROMICS): A Valuable Resource for Advancing Precision Medicine in Stroke Diagnosis and Treatment
    WANG Xiujie, XU Anding
    2024, 19(12):  1369-1371.  DOI: 10.3969/j.issn.1673-5765.2024.12.001
    Asbtract ( )   PDF (1893KB) ( )  
    References | Related Articles | Metrics
    Currently, stroke treatment faces the dilemma of limited therapeutic drugs and slow progress in new drug development globally, partly due to the lack of multi-omics and multimodal databases with comprehensive follow-up data from large-scale stroke cohorts. The Chinese stroke omics atlas (STROMICS) has released the whole-genome sequencing results from a cohort of ten thousand Chinese patients with ischemic stroke. This database integrates multi-omics data, including proteomics, and metabolomics, from approximately 15 000 patients with ischemic stroke. Additionally, it incorporates more than 2700 clinical phenotypes, 189 biomarker test results, various imaging data, clinical examinations, diagnoses, treatments, and follow-up records. By establishing the first multi-omics and multimodal data platform for a cohort of ten thousand Chinese stroke patients (http://www.stromics.org.cn), STROMICS addresses the lack of multi-omics and multimodal data for Chinese patients in the previous global stroke research field. It serves as a valuable resource for promoting stroke mechanism research and precision medicine.
    The 2024 Guideline for the Primary Prevention of Stroke: Ten Years of Hard and Persistent Effort
    ZHENG Huaguang, LI Hao, WANG Yongjun
    2024, 19(12):  1372-1375.  DOI: 10.3969/j.issn.1673-5765.2024.12.002
    Asbtract ( )   PDF (1667KB) ( )  
    References | Related Articles | Metrics
    A ten-year effort is just for this day, the 2024 guideline for the primary prevention of stroke from the American Heart Association/American Stroke Association was published in December 2024. Compared to the previous edition in 2014, the 2024 guideline focuses on macro-social factors, overall evaluation and management of the risk factors, holistic prevention (including non-atherosclerotic stroke), and paying attention to special populations and specific risk factors. For people with a moderate risk of cardiovascular and cerebrovascular disease, the current research evidence for the primary prevention of stroke is not yet sufficient to confirm the effectiveness and safety of aspirin. Methods such as multi-omics, artificial intelligence, big data, and simulated randomized controlled trials need to be combined to select patient-centered research endpoints to refine the evidence and guide practice.
    Application Research and Prospect of Metabolomics in Ischemic Stroke
    TANG Yixin, TU Ruxin, XIA Jian
    2024, 19(12):  1376-1381.  DOI: 10.3969/j.issn.1673-5765.2024.12.003
    Asbtract ( )   PDF (1652KB) ( )  
    References | Related Articles | Metrics
    Metabolomics has important application value in the study of ischemic stroke. This article reviews the progress of metabolomics methods in revealing the pathogenesis of ischemic stroke, predicting disease risk, assisting clinical diagnosis, optimizing treatment strategies, and evaluating prognosis. Studies have shown that metabolomics can reveal various metabolic abnormalities in the occurrence and development of ischemic stroke, providing clues for exploring pathological mechanisms. Through identifying metabolic biomarkers, it can effectively predict disease risk and help with early diagnosis. When combined with artificial intelligence to build early diagnosis models, it helps to distinguish stroke subtypes, clarify metabolic differences between different types of stroke, and improve diagnostic accuracy. By monitoring changes in metabolites during post-stroke treatment and functional recovery, it reveals new potential therapeutic targets. In the future, metabolomics is anticipated to serve as a scientific basis for personalized intervention and precision medicine in ischemic stroke.
    Metabolomics Research in Cerebrovascular Diseases
    XIA Jian
    2024, 19(12):  1382-1382. 
    Asbtract ( )   PDF (1555KB) ( )  
    Related Articles | Metrics
    Correlation between Gut Microbiota Dysbiosis and Poor Functional Prognosis in Patients with Acute Mild Ischemic Stroke
    REN Yueran, LIANG Jingru, ZHENG Yifeng, YIN Jia
    2024, 19(12):  1383-1391.  DOI: 10.3969/j.issn.1673-5765.2024.12.004
    Asbtract ( )   PDF (6712KB) ( )  
    References | Related Articles | Metrics
    Objective  To investigate the relationship between gut microbiota and clinical prognosis in acute mild ischemic stroke (MIS) patients by establishing a cohort of patients with MIS, and to identify intervention targets for poor functional prognosis.
    Methods  Patients with acute MIS (NIHSS score≤5 points) were prospectively and continuously enrolled in this study. These patients were admitted to the Department of Neurology at Nanfang Hospital, Southern Medical University between September 2018 and March 2023, within 7 days of the onset of the stroke events. According to the results of a 90-day follow-up, the patients were divided into the good prognosis (mRS score≤2 points) group and the poor prognosis (mRS score >2 points) group. Stool samples were collected from all patients within 24 hours of admission, and the gut microbiota composition was analyzed using 16S ribosomal RNA high-throughput sequencing. The effects of clinical characteristics and gut microbiota-related indicators on the poor prognosis of MIS patients were analyzed. Additionally, clinical prediction models were established to assess the risk of poor prognosis of MIS patients based on gut microbiota.
    Results  There were significant differences in the composition of gut microbiota between MIS patients with poor and good prognoses (P=0.001). In terms of the gut microbiota composition, linear discriminant analysis effect size revealed that Escherichia Shigella was the dominant genera in patients with poor prognosis, while the abundance of Firmicutes and Clostridia were significantly enriched in patients with good prognosis. Further correlation analysis showed that the abundance of Escherichia Shigella was positively correlated with the neutrophil-to-lymphocyte ratio, the platelet-to-lymphocyte ratio, and the systemic immune-inflammation index. Multivariate logistic regression analysis showed that the increased abundance of Firmicutes (OR 0.587, 95%CI 0.351-0.980, P=0.042) and Clostridia (OR 0.577, 95%CI 0.341-0.977, P=0.041) after adjustment was a protective factor for poor  functional prognosis, whereas the increased abundance of Escherichia Shigella (OR 2.483, 95%CI 1.370-4.500, P=0.003) was an independent risk factor for poor  functional prognosis. By combining the Firmicutes, Clostridia, and Escherichia Shigella with clinical indicators, predictive models for poor functional prognosis were established, with AUC values of 0.842 (95%CI 0.756-0.928), 0.840 (95%CI 0.752-0.928), and 0.863 (95%CI 0.787-0.939), respectively.
    Conclusions  The abundance of Firmicutes, Clostridia, and Escherichia Shigella may serve as potential biomarkers for predicting the clinical functional prognosis of MIS patients.
    Cerebral Small Vessel Disease and Metabolism: Risk Factors, Therapeutic Targets, and Future Directions
    QIU Yue, XU Yang, XUE Jing, XU Jie, WANG Yilong
    2024, 19(12):  1392-1399.  DOI: 10.3969/j.issn.1673-5765.2024.12.005
    Asbtract ( )   PDF (1723KB) ( )  
    References | Related Articles | Metrics
    It is crucial to identify the metabolic risk factors of cerebral small vessel disease (CSVD) and implement timely and systematic management. Currently, the correlation between residual metabolic risk factors and CSVD is still controversial, and there’s a lack of evidence-based support for the clinical efficacy of targeting risk factors in treating CSVD. This paper comprehensively analyzes the correlation between residual metabolic risk factors such as inflammation, gut microbiota dysbiosis, hyperhomocysteinemia, and hyperuricemia with the occurrence and development of CSVD. It further explores potential therapeutic options targeting metabolic risk factors, emphasizes the important role of metabolomics in the discovery of novel metabolic biomarkers and the establishment of risk prediction models for CSVD, and looks forward to future research directions, to provide a theoretical basis for the early diagnosis, mechanism exploration, risk factor management, and comprehensive multidisciplinary management of CSVD.
    Residual Metabolic Risk Factors and Stroke in Young Adults
    QIAN Yutong, ZHANG Shufan, HAN Zhenxiang, WU Weicheng, HAN Xiang
    2024, 19(12):  1400-1408.  DOI: 10.3969/j.issn.1673-5765.2024.12.006
    Asbtract ( )   PDF (1735KB) ( )  
    References | Related Articles | Metrics
    The stroke in young adults is generally defined as a stroke occurring in the age range of 18 to 50 years. The increasing incidence rate of this condition has resulted in a significant socio-economic burden in China. In addition to the traditional metabolic risk factors for stroke in young adults, such as hypertension, abnormal glucose metabolism, abnormal lipid metabolism, and obesity, residual metabolic risk factors should not be overlooked. This article focuses on the influence of four residual metabolic risk factors on stroke in young adults: inflammation, hyperhomocysteinemia, hyperuricemia, and gut microbiota metabolites. Inflammation plays a significant role in young adult stroke and is closely related to the occurrence and development of cardiogenic cerebral embolism, an important cause in this age group. Hyperhomocysteinemia promotes thrombosis by affecting vascular endothelium and coagulation function, which is a promising indicator for predicting stroke risk and prognosis. The detection rate of hyperhomocysteinemia is high in young stroke patients. Hyperuricemia is associated with a number of vascular risk factors and metabolic syndrome through oxidative stress and inflammatory responses, increasing the risk of stroke in young adults. The gut microbiota interacts with stroke in young adults through the gut-brain axis, and its metabolites such as trimethylamine N-oxide and short-chain fatty acids are associated with stroke risk and prognosis. This article emphasizes the importance of further research into the effects of these residual metabolic risk factors on stroke in young adults and suggests directions for future research, including large-scale prospective studies designed by age stratification. Early identification and management of these metabolic risk factors can provide a reference for the prevention, treatment, and prognosis of stroke in young adults, thereby reducing the socio-economic burden of young adult stroke.
    Advances of Oxylipins in Cerebrovascular Diseases
    CHENG Liuyang, FAN Zheting, XIA Jian
    2024, 19(12):  1409-1418.  DOI: 10.3969/j.issn.1673-5765.2024.12.007
    Asbtract ( )   PDF (2100KB) ( )  
    References | Related Articles | Metrics
    Oxylipins are bioactive lipids formed by the oxidation of polyunsaturated fatty acids. In recent years, an increasing number of studies have demonstrated that oxylipins can influence the occurrence and development of cerebrovascular diseases through diverse mechanisms such as inflammation response, oxidative stress, apoptosis, and vascular homeostasis. Besides, clinical studies based on metabolomics have found that there are differences in the levels of oxylipins in patients with different phenotypes or prognosis of cerebrovascular diseases. Studying the roles of oxylipins in cerebrovascular diseases can provide new insights and approaches for the diagnosis, treatment and prevention of cerebrovascular diseases.
    Effects of Atrial Fibrillation on Long-Term Prognosis of Patients with Multiple Nonlacunar Cerebral Infarctions
    DING Yarong, YAN Hongyi
    2024, 19(12):  1419-1425.  DOI: 10.3969/j.issn.1673-5765.2024.12.008
    Asbtract ( )   PDF (2086KB) ( )  
    References | Related Articles | Metrics
    Objective  To analyze the differences of clinical characteristics and prognosis in patients with multiple nonlacunar cerebral infarctions with or without atrial fibrillation (AF).
    Methods  This study was based on data from the third China national stroke registry (CNSR-Ⅲ), a national multicenter prospective study conducted from August 2015 to March 2018. Patients with multiple (2 or more infarctions) acute nonlacunar cerebral infarctions confirmed by head MRI were included. The baseline information, medical history, medication history during hospitalization, TOAST classification and other clinical data were collected. Follow-ups at 3 months and 1 year were conducted to assess outcomes, including stroke recurrence (ischemic stroke and hemorrhagic stroke), composite vascular events (stroke, myocardial infarction, and vascular death), cerebrovascular disease-related death, and unfavorable functional outcomes (mRS score>2). Patients were divided into the AF group and the non-AF group based on whether they had a history of AF. The demographic information and clinical characteristics were compared between the two groups. Analyzing the effects of AF on the outcomes of patients at 3 months and 1 year, and further analyzing the relationship between AF and the 1-year outcomes of patients with infarctions in different vascular distribution subgroups (multiple unilateral anterior circulation infarctions, multiple posterior circulation infarctions, and multiple vascular infarctions). 
    Results  A total of 5711 patients with multiple nonlacunar cerebral infarctions were included, with a mean age of (62.8±11.4) years, and 1702 (29.8%) were female. Among these, 611 patients (10.7%) had AF, while 5100 patients (89.3%) did not. Compared with the non-AF group, the age of the AF group was higher, and the proportion of female, coronary artery heart disease, and tumor history was higher. BMI, the proportion of hypertension, diabetes mellitus, TIA, and the proportion of prior smoking and alcohol use were lower. The differences were statistically significant. The distribution differences of TOAST classification between the two groups were also statistically significant. Among them, the proportion of cardioembolic stroke and stroke of undetermined causes in the AF group was higher than that in the non-AF group. Laboratory results showed that the levels of HDL-C, D-dimer, and fibrinogen in the AF group were higher than those in the non-AF group. Multivariate analysis showed that the proportion of unfavorable functional outcomes at 1 year in the AF group was higher than that in the non-AF group, and the difference was statistically significant (adjusted OR 1.35, 95%CI 1.10-1.67, P=0.005). In the multiple unilateral anterior circulation infarctions subgroup, the rates of composite vascular events (adjusted HR 1.31, 95%CI 1.00-1.70, P=0.047), cerebrovascular disease-related death (adjusted HR 3.17, 95%CI 1.63-6.18, P<0.001), and unfavorable functional outcomes (adjusted OR 1.39, 95%CI 1.09-1.77, P=0.007) in patients with AF at 1 year were higher than those without AF.
    Conclusions  Significant differences were observed in clinical characteristics between patients with multiple nonlacunar cerebral infarctions with and without AF. Patients with AF had a higher incidence of unfavorable functional outcomes at 1 year, especially in those with multiple unilateral anterior circulation infarctions. AF was a risk factor for composite vascular events, cerebrovascular disease-related death, and unfavorable functional outcomes at 1 year. 
    Causality between Chronic Kidney Disease and Stroke: A Two-Sample Bidirectional Mendelian Randomization Study
    SONG Jinyun, ZHAO Hongyu
    2024, 19(12):  1426-1432.  DOI: 10.3969/j.issn.1673-5765.2024.12.009
    Asbtract ( )   PDF (2443KB) ( )  
    References | Related Articles | Metrics
    Objective  Two-sample bidirectional Mendelian randomization (MR) method was used to analyze the causality between chronic kidney disease (CKD) and stroke. 
    Methods  With CKD as the exposure factor and stroke as the outcome variable, the forward study obtained the genome-wide association study data for CKD and stroke, and screened out the single nucleotide polymorphisms (SNPs) significantly associated with CKD as instrumental variables. The reverse study screened SNPs closely related to stroke as instrumental variables, with CKD as the outcome variable. Inverse variance weighted, weighted median, and MR-Egger regression were used for bidirectional MR analysis to explore the causality between CKD and stroke. Heterogeneity was evaluated using Cochran’s Q test, pleiotropy was tested using the intercept term of MR-Egger regression, and sensitivity analysis was performed using the leave-one-out to evaluate the robustness of the MR results. 
    Results  In the forward study, four SNPs significantly correlated with CKD were obtained as the final instrumental variables, and the results of inverse variance weighted showed a significant positive causality between CKD and stroke (OR 1.123, 95%CI 1.051-1.200, P<0.001). Reverse MR results showed that stroke also increased the risk of CKD (OR 1.213, 95%CI 1.003-1.466, P=0.046). No heterogeneity or horizontal pleiotropy was found (both P>0.05) , and the results of MR analysis were robust after removing SNPs one by one.
    Conclusions  Bidirectional causality was observed between CKD and stroke. CKD increases the risk of stroke, and stroke also increases the risk of CKD.
    Correlation between Lipid Parameters and Carotid Plaque in the Neurologically Healthy Population
    LI Wenbo, LIU Yang, LIU Jie, GUO Qirui, ZHANG Ying, ZHENG Huaguang
    2024, 19(12):  1433-1440.  DOI: 10.3969/j.issn.1673-5765.2024.12.010
    Asbtract ( )   PDF (2080KB) ( )  
    References | Related Articles | Metrics
    Objective  To explore the correlation between lipid parameters and carotid plaque (CP) in the neurologically healthy population.
    Methods  This retrospective study consecutively enrolled neurologically healthy individuals who underwent health examinations at the Health Management Center of Beijing Tiantan Hospital, Capital Medical University from October 2022 to October 2023. Subjects completed standardized questionnaires, physical examinations, cervical vascular ultrasound, and laboratory tests. CP was evaluated by standard carotid ultrasound imaging. CP was defined as carotid intima-media thickness≥1.5 mm. Logistic regression and restricted cubic spline (RCS) were used to analyze the correlation between lipid parameters and CP. Additionally, ROC curves were plotted, and the predictive ability of lipid parameters for CP was evaluated using indicators such as AUC, 95%CI, and optimal cutoff values.
    Results  A total of 13 939 subjects were included, with a median age of 42 (35-52) years. Among them, 7501 (53.81%) were female, and 2936 (21.06%) had CP. Multivariate logistic regression analysis showed that after adjusting for confounding factors, compared to the low level group, high levels of TC, TG, LDL-C, HDL-C, residual cholesterol, non-high-density lipoprotein cholesterol, apolipoprotein B, and the apolipoprotein B/apolipoprotein A1 ratio were positively correlated with CP. Conversely, high levels of HDL-C and apolipoprotein A1 were negatively correlated with CP. Among them, the apolipoprotein B/apolipoprotein A1 ratio showed the strongest correlation with CP (OR 1.85, 95%CI 1.59-2.16, P<0.001; P for trend<0.001). RCS curves showed that except for HDL-C and apolipoprotein A1, other lipid parameters exhibited a nonlinear relationship with CP. Residual cholesterol had the best predictive effect for CP among all lipid parameters, with an AUC value of 0.65 (95%CI 0.64-0.66), and the optimal cutoff value was 0.33 mmol/L.
    Conclusions  Lipid parameters were independently correlated with CP in the neurologically healthy population, and the apolipoprotein B/apolipoprotein A1 ratio had the strongest correlation with CP. Residual cholesterol was the best lipid parameter in identifying CP.
    Predictive Value of Serum miR-491-5p and miR-21-5p on Hemorrhagic Transformation after Intravenous Thrombolysis in Acute Ischemic Stroke Patients
    WANG Xiaohan, PAN Yan, ZHANG Xiaolin, LIU Tan
    2024, 19(12):  1441-1447.  DOI: 10.3969/j.issn.1673-5765.2024.12.011
    Asbtract ( )   PDF (2337KB) ( )  
    References | Related Articles | Metrics
    Objective  To investigate the predictive value of serum microRNA-491-5p (miR-491-5p) and microRNA-21-5p (miR-21-5p) for hemorrhagic transformation after intravenous thrombolysis in  patients with acute ischemic stroke (AIS). 
    Methods  A total of 312 patients with AIS who underwent intravenous thrombolysis at Nanyang Central Hospital from January 2021 to February 2023 were retrospectively selected as the study objects. They were divided into the hemorrhagic transformation group (66 cases) and the non-hemorrhagic transformation group (246 cases) according to the occurrence of hemorrhagic transformation 24 hours after intravenous thrombolysis. Realtime fluorescence quantitative PCR was used to measure the expression levels of serum miR-491-5p and miR-21-5p. Multivariate logistic regression analysis was used to explore the independent risk factors for hemorrhagic transformation after intravenous thrombolysis in AIS patients. The predictive value of serum miR-491-5p, miR-21-5p, and their combination for hemorrhagic transformation after intravenous thrombolysis in AIS patients was analyzed by ROC curve.  
    Results  The proportion of patients with diabetes mellitus, hypertension, and atrial fibrillation in the hemorrhagic transformation group was higher than that in the non-hemorrhagic transformation group (P<0.001). The levels of random blood glucose, NIHSS score, and serum miR-21-5p expression in the hemorrhagic transformation group were also higher than those in the non-hemorrhagic transformation group (P<0.001), while the expression level of serum miR-491-5p was lower than that in the non-hemorrhagic transformation group (P<0.001). Logistic regression analysis showed that a history of diabetes mellitus (OR 1.907, 95%CI 1.088-3.344), a history of hypertension (OR 1.928, 95%CI 1.105-3.364), a history of atrial fibrillation (OR 2.375, 95%CI 1.356-4.159), elevated random blood glucose level (OR 1.826, 95%CI 1.062-3.138), increased NIHSS score (OR 3.894, 95%CI 1.568-9.671), and elevated expression level of serum miR-21-5p (OR 4.237, 95%CI 1.643-10.925) were independent risk factors for hemorrhagic transformation after intravenous thrombolysis in AIS patients (P<0.001). Conversely, elevated expression level of serum miR-491-5p (OR 0.193, 95%CI 0.108-0.347) was the protective factor for hemorrhagic transformation after intravenous thrombolysis in AIS patients (P<0.001). The ROC curve showed that the AUC values of serum miR-491-5p and miR-21-5p expression levels for predicting hemorrhagic transformation after intravenous thrombolysis in AIS patients were 0.784 (95%CI 0.731-0.838) and 0.785 (95%CI 0.722-0.847), respectively. The corresponding optimal cutoff values were 1.21 and 2.26, respectively. The AUC value predicted by the combination of the two increased to 0.861 (95%CI 0.815-0.907).
    Conclusions  Low expression level of serum miR-491-5p and high expression level of miR-21-5p are independent risk factors for hemorrhagic transformation after intravenous thrombolysis in AIS patients. They can be used as risk predictors for hemorrhagic transformation, with good combined predictive efficacy.
    Evaluation Value of Systemic Immune-Inflammation Index and C-Reactive Protein/Albumin Ratio in Short-Term Prognosis of Patients with Acute Ischemic Stroke after Thrombolytic Therapy
    LIU Xiaomei, GOU Zhongji, FU Li
    2024, 19(12):  1448-1453.  DOI: 10.3969/j.issn.1673-5765.2024.12.012
    Asbtract ( )   PDF (2144KB) ( )  
    References | Related Articles | Metrics
    Objective  To investigate the predictive effects of systemic immune-inflammation index (SII) and CRP/albumin (ALB) on short-term prognosis of acute ischemic stroke (AIS) patients receiving thrombolytic therapy with rt-PA. 
    Methods  The clinical data of AIS patients who received rt-PA thrombolytic therapy in The People’s Hospital of Pengzhou from January to December 2022 were retrospectively analyzed. The mRS was used to evaluate the prognosis of patients 30 days after the onset of the disease. The mRS score of≤2 points was considered a good prognosis, while mRS score>3 points was considered a poor prognosis. SII and CRP/ALB were calculated from peripheral blood test results at admission. The factors influencing prognosis of AIS patients were analyzed by univariate and logistic multivariate analysis. The predictive effects of SII and CRP/ALB on the prognosis of AIS patients were analyzed using the ROC curve. 
    Results  A total of 134 AIS patients were included in this study, of which 29 patients (21.64%) had poor prognosis. Univariate analysis showed that NIHSS score, platelet count, D-dimer, prothrombin time, TC, CRP, SII, and CRP/ALB in patients with poor prognosis were higher than those with good prognosis, and the differences were statistically significant (P<0.05). The lymphocyte count and ALB in patients with poor prognosis were lower than those with good prognosis, and the differences were statistically significant (P<0.05). Logistic multivariate analysis showed that NIHSS score (OR 19.028, 95%CI 2.785-27.348, P<0.001), TC (OR 6.979, 95%CI 1.851-12.191, P=0.009), CRP (OR 7.830, 95%CI 2.559-14.252, P=0.002), ALB (OR 0.192, 95%CI 0.101-0.662, P<0.001), SII (OR 9.244, 95%CI 2.571-19.379, P<0.001), and CRP/ALB (OR 11.100, 95%CI 3.570-22.451, P<0.001) were independent influencing factors of poor prognosis. ROC curve analysis showed that SII and CRP/ALB had predictive value for poor prognosis, with AUC of 0.648 (95%CI 0.529-0.767, P=0.015) and 0.749 (95%CI 0.664-0.883, P<0.001), sensitivity of 0.448 and 0.931, and specificity of 0.876 and 0.562, respectively. 
    Conclusions  SII and CRP/ALB are independent influencing factors for poor prognosis of patients, and combined assessment of SII and CRP/ALB is helpful for early identification of high-risk AIS patients. 
    Chinese Stroke Association Guidelines on Emergency Stroke Unit
    Emergency Stroke Unit Alliance, Chinese Stroke Association
    2024, 19(12):  1454-1459.  DOI: 10.3969/j.issn.1673-5765.2024.12.013
    Asbtract ( )   PDF (2190KB) ( )  
    References | Related Articles | Metrics
    Organized stroke care has become a keystone in delivering efficient and effective treatment to stroke patients with improved outcomes. Delivering timely acute reperfusion therapy to those with acute ischemic strokes is key to good recovery. Emergency stroke unit (ESU) is a novel organized stroke care system developed in China. It centralizes all necessary procedures for the diagnosis and treatment of acute stroke into one unit that can perform clinical assessment, imaging examination, and acute treatment. In ESU, artificial intelligence algorithms is used to aid reading brain images and making clinical decisions. Therefore, ESU can significantly enhance the efficiency of emergent stroke care. In this guideline, we aim to clarify the concept, construction standards and personnel requirements of an ESU, standardize ESU-based acute stroke triage and treatment workflow, establish metrics of quality control, facilitate the construction and promotion of ESU, and continue the improvement of the quality of stroke care.
    Chinese Stroke Association Guidelines on Reperfusion Therapy for Acute Ischemic Stroke 2024
    Chinese Stroke Association, Writing Group of Chinese Stroke Association Guidelines on Reperfusion Therapy for Acute Ischemic Stroke
    2024, 19(12):  1460-1478.  DOI: 10.3969/j.issn.1673-5765.2024.12.014
    Asbtract ( )   PDF (2356KB) ( )  
    References | Related Articles | Metrics
    Recently, significant progress has been made in clinical trials in the field of intravenous thrombolysis and mechanical thrombectomy for acute ischemic stroke. New research results continuously expanded the indications for both intravenous thrombolysis and mechanical thrombectomy. Based on these advancements, the Writing Group of Chinese Stroke Association Guidelines on Reperfusion Therapy for Acute Ischemic Stroke 2024 invited experts in the field of stroke in China to extensively discuss the existing evidence on reperfusion therapy for acute ischemic stroke, resulting in graded recommendations. This guideline outlines the latest screening criteria for intravenous thrombolysis and mechanical thrombectomy and summarizes the current evidence on different thrombolytic drug options, in order to provide a reference for decision-making on reperfusion therapy of acute ischemic stroke.
    Interpretation of the Keypoints and Updates on 2024 Guideline for the Primary Prevention of Stroke: A Guideline from the American Heart Association/American Stroke Association
    DAI Liye, YAO Jingfan, ZHANG Runhua, YANG Xin, ZHAI Yi, LIU Gaifen, JIANG Yong
    2024, 19(12):  1479-1485.  DOI: 10.3969/j.issn.1673-5765.2024.12.015
    Asbtract ( )   PDF (1662KB) ( )  
    References | Related Articles | Metrics
    In 2024, the American Heart Association and the American Stroke Association released the 2024 guideline for the primary prevention of stroke. Based on the latest evidence-based medical evidence in the past decade, this guideline provides stroke prevention strategies for people without a history of stroke. This article analyzes the key recommendations of this guideline, combines the latest research results in the field of stroke prevention, and interprets relevant literature, aiming to clearly present the latest suggestions on stroke screening and prevention, and provide practical guidance for the public and medical staff.
    Overview of Medical Quality Research Theory and Practice in Cerebrovascular Diseases
    YAN Haoyu, WANG Chunjuan, YANG Xin, ZHAI Yi, LI Zixiao, GU Hongqiu
    2024, 19(12):  1486-1494.  DOI: 10.3969/j.issn.1673-5765.2024.12.016
    Asbtract ( )   PDF (2341KB) ( )  
    References | Related Articles | Metrics
    Medical quality is one of the most important public health problems, profoundly impacting public well-being. Cerebrovascular diseases rank first in China’s disease burden. Current research and actions on the medical quality of cerebrovascular diseases lack a systematic theoretical guidance framework. This paper introduces the concept of medical quality, the selection of relevant indicators, data sources, and commonly used theoretical models. It enumerates practical cases of medical quality research on cerebrovascular diseases and constructs a complete framework from theory to practice. This paper aims to provide clear theoretical assistance and practical references for improving the medical quality in the field of cerebrovascular diseases.